| Nicole Augusta Stivers, MD | |
|
8971 W Overland Rd, Boise, ID 83709-1651 | |
| (208) 378-4288 | |
| Not Available |
| Full Name | Nicole Augusta Stivers |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 21 Years |
| Location | 8971 W Overland Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558370254 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 200121 (Louisiana) | Secondary |
| 207Q00000X | Family Medicine | M-14377 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| First Choice Home Care | Boise, ID | Home health agency |
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
| Saint Alphonsus Medical Center - Nampa | Nampa, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alliance Medical Group Llc | 3971544685 | 120 |
News Archive
A possible reason why the Northwick Park clinical trial of the drug TGN1412 caused multiple organ failure in human volunteers is revealed in research presented at a conference near Paris.
Loxo Oncology, Inc., a biopharmaceutical company focused on developing targeted cancer therapies for genetically-defined populations, announced today that it has closed a $24 million Series B private financing round led by New Enterprise Associates.
Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way.
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
› Verified 7 days ago
| Entity Name | Alliance Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568413920 PECOS PAC ID: 3971544685 Enrollment ID: O20050512000561 |
News Archive
A possible reason why the Northwick Park clinical trial of the drug TGN1412 caused multiple organ failure in human volunteers is revealed in research presented at a conference near Paris.
Loxo Oncology, Inc., a biopharmaceutical company focused on developing targeted cancer therapies for genetically-defined populations, announced today that it has closed a $24 million Series B private financing round led by New Enterprise Associates.
Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way.
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Augusta Stivers, MD Po Box 191050, Boise, ID 83719-1050 Ph: (208) 955-6500 | Nicole Augusta Stivers, MD 8971 W Overland Rd, Boise, ID 83709-1651 Ph: (208) 378-4288 |
News Archive
A possible reason why the Northwick Park clinical trial of the drug TGN1412 caused multiple organ failure in human volunteers is revealed in research presented at a conference near Paris.
Loxo Oncology, Inc., a biopharmaceutical company focused on developing targeted cancer therapies for genetically-defined populations, announced today that it has closed a $24 million Series B private financing round led by New Enterprise Associates.
Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way.
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
› Verified 7 days ago
Dr. Maureen A Newman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-302-5480 | |
Jessica A Evert, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-7350 | |
Tracy Adams, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-514-2500 | |
Sarah A Hershman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-514-2500 Fax: 208-375-2217 | |
Summer E Szumski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-514-2500 Fax: 208-375-2217 | |
Dr. Thornton E Bryan Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Parkcenter Blvd, Boise, ID 83706 Phone: 208-381-6500 Fax: 208-381-6505 | |
Irvin E Sackman Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 E Boise Ave, Boise, ID 83706 Phone: 208-345-4066 Fax: 208-345-4196 |